首页> Pharmacogenomics> PARC report: a perspective on the state of clinical pharmacogenomics testing.

PARC report: a perspective on the state of clinical pharmacogenomics testing.

导出原文传递

翻译打印收藏纠错

第一作者： Jennifer,Eichmeyer

第一单位： School of Allied Health Sciences, Boise State University, Boise, ID 83725, USA.

作者： Jennifer,Eichmeyer ^[1] ; Sara,Rogers ^[2] ; Christine M,Formea ^[3] ; Jyothsna,Giri ^[4] ; J Shawn,Jones ^[5] ; Erica,Schnettler ^[6] ; Tara,Schmidlen ^[7] ; Emily,Glogowski ^[8] ; Raluca N,Kurz ^[9]

作者单位： School of Allied Health Sciences, Boise State University, Boise, ID 83725, USA. ^[1] American Society of Pharmacovigilance, Houston, TX 77225, USA. ^[2] Department of Pharmacy Services, Intermountain Healthcare, Salt Lake City, UT 84123, USA.;Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA. ^[3] Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA. ^[4] Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX 75216, USA. ^[5] OneOme, LLC, Minneapolis, MN 55413, USA. ^[6] Genomic Medicine Institute, Geisinger, Danville, PA 17822, USA. ^[7] GeneDx, Gaithersburg, MD 20877, USA. ^[8] Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA. ^[9]

关键词 direct-to-consumer testing genetic testing liability malpractice patient access payers personalized medicine pharmacogenetics pharmacogenomics reimbursement

医学主题词费用效益分析(Cost-Benefit Analysis);药物标签(Drug Labeling);人类(Humans);职业过失(Malpractice)

DOI 10.2217/pgs-2019-0193

PMID 32635876

发布时间 2021-06-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交